or Try an Advanced Search...

    Astellas Pharma Stocks List

    Symbol Grade Name % Change
    AMGN A Amgen Inc. 11.82
    CYTK D Cytokinetics, Incorporated 1.45
    IRWD F Ironwood Pharmaceuticals, Inc. -2.17
    RPRX D Royalty Pharma plc -1.22
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biotechnology Human Therapeutic Products Neuroscience Pharmaceutical Products Therapeutic Products Amyotrophic Lateral Sclerosis Biopharmaceutical Biopharmaceutical Products Blood Cells Bone Bone Disease Cancer Care Cardiovascular Disease Central Nervous System Disorders Chronic Idiopathic Constipation Clinic Clinical Development Constipation Cytokine Dialysis

    Related ETFs - A few ETFs which own one or more of the above listed Astellas Pharma stocks.

    Symbol Grade Name Weight
    BBH B Market Vectors Biotech ETF 15.98
    IBBQ C Invesco Nasdaq Biotechnology ETF 10.75
    IBB C iShares Nasdaq Biotechnology Index Fund 9.5
    BIS D ProShares UltraShort Nasdaq Biotechnology 8.38
    BIB C ProShares Ultra Nasdaq Biotechnology 7.95
    View all Astellas Pharma ETFs...
    Compare ETFs
    Compare IBB to BIS Compare IBBQ to BIB Compare IBBQ to BIS

        Astellas Pharma Stocks Recent News

        Date Stock Title
        May 3 AMGN Why Amgen Stock Zoomed Nearly 12% Higher Today
        May 3 AMGN Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
        May 3 AMGN Analyst unveils Amgen stock price target after weight-loss drug data
        May 3 AMGN Amgen's Q1 Earnings: Solid All Court Progress, Major Weight Loss Catalyst Pending
        May 3 AMGN Interest rate cuts could switch ‘from stroll to a sprint’ after US jobs surprise
        May 3 AMGN William Blair, Barclays upgrade Amgen following GLP-1 drug update
        May 3 AMGN Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition
        May 3 AMGN US STOCKS-Wall St rallies after soft jobs data allays rate jitters
        May 3 AMGN Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
        May 3 AMGN Weight-loss drug competition heats up. Is Wegovy in trouble?
        May 3 AMGN Amgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript
        May 3 AMGN Dow Jones Soars 400 Points As Amgen, Apple Surge; Nvidia Jumps Again, Tempts New Buyers
        May 3 AMGN US STOCKS-Wall St gains after soft jobs data allays rate jitters
        May 3 AMGN Amgen stock rallies 13% on GLP-1 weight-loss drug update
        May 3 AMGN Amgen Knocks Novo Nordisk's Ozempic Stock Rally
        May 3 AMGN Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
        May 3 AMGN Amgen surges over confidence in early obesity drug results
        May 3 AMGN These Two Stocks Are Driving the Dow Friday
        May 3 AMGN Stocks to Watch Friday: Apple, Amgen, Coinbase, Block
        May 3 AMGN Amgen upgraded, Peloton downgraded: Wall Street's top analyst calls
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biotechnology Human Therapeutic Products Neuroscience Pharmaceutical Products Therapeutic Products Amyotrophic Lateral Sclerosis Biopharmaceutical Biopharmaceutical Products Blood Cells Bone Bone Disease Cancer Care Cardiovascular Disease Central Nervous System Disorders Chronic Idiopathic Constipation Clinic Clinical Development Constipation Cytokine Dialysis
        Astellas Pharma

        Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd. (藤沢薬品工業株式会社, Fujisawa Yakuhin Kōgyō Kabushiki-gaisha).
        Astellas is a member of the Mitsubishi UFJ Financial Group (MUFJ) keiretsu.

        More about Astellas Pharma
        Browse All Tags